Healthcare - Medical - Care Facilities - NYSE - US
$ 14.15
-4.13 %
$ 1.22 B
Market Cap
-6.05
P/E
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients.[ Read More ]
The intrinsic value of one MD stock under the base case scenario is HIDDEN Compared to the current market price of 14.2 USD, Pediatrix Medical Group, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart MD
FINANCIALS
1.99 B
REVENUE
7.32 M
OPERATING INCOME
-60.4 M
NET INCOME
137 M
OPERATING CASH FLOW
-48.2 M
INVESTING CASH FLOW
-25.7 M
FINANCING CASH FLOW
511 M
REVENUE
33.8 M
OPERATING INCOME
19.4 M
NET INCOME
101 M
OPERATING CASH FLOW
-4.34 M
INVESTING CASH FLOW
-3.07 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Pediatrix Medical Group, Inc.
| Current Assets | 483 M |
| Cash & Short-Term Investments | 178 M |
| Receivables | 280 M |
| Other Current Assets | 25.8 M |
| Non-Current Assets | 1.74 B |
| Long-Term Investments | 0 |
| PP&E | 146 M |
| Other Non-Current Assets | 1.59 B |
| Current Liabilities | 389 M |
| Accounts Payable | 34.6 M |
| Short-Term Debt | 59.5 M |
| Other Current Liabilities | 295 M |
| Non-Current Liabilities | 982 M |
| Long-Term Debt | 666 M |
| Other Non-Current Liabilities | 316 M |
EFFICIENCY
Earnings Waterfall
Pediatrix Medical Group, Inc.
| Revenue | 1.99 B |
| Cost Of Revenue | 1.57 B |
| Gross Profit | 422 M |
| Operating Expenses | 414 M |
| Operating Income | 7.32 M |
| Other Expenses | 67.7 M |
| Net Income | -60.4 M |
RATIOS
21.13%
GROSS MARGIN
0.37%
OPERATING MARGIN
-3.03%
NET MARGIN
-7.11%
ROE
-2.72%
ROA
0.61%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Pediatrix Medical Group, Inc.
| Net Income | -60.4 M |
| Depreciation & Amortization | 36.2 M |
| Capital Expenditures | -33.3 M |
| Stock-Based Compensation | 12.3 M |
| Change in Working Capital | -11.6 M |
| Others | 120 M |
| Free Cash Flow | 104 M |
Wall Street Analysts Price Targets
Pediatrix Medical Group, Inc.
Wall Street analysts predict an average 1-year price target for MD of $11.2 , with forecasts ranging from a low of $8 to a high of $14 .
MD Lowest Price Target
Wall Street Target
8 USD
-43.46%
MD Average Price Target
Wall Street Target
11.2 USD
-20.49%
MD Highest Price Target
Wall Street Target
14 USD
-1.06%
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Pediatrix Medical Group, Inc.
Sold
0-3 MONTHS
751 K USD 4
3-6 MONTHS
504 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
75.6 K USD 2
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
4 days ago
Nov 13, 2024
|
Sell 424 K USD
|
ORDAN MARK S
Director |
- 27600
|
15.35 USD |
|
1 week ago
Nov 08, 2024
|
Sell 130 K USD
|
Moore Mary Ann E
EVP, GC, Chief Admin Off & Sec |
- 8108
|
16 USD |
|
2 months ago
Aug 30, 2024
|
Sell 120 K USD
|
Swift James D
Chief Executive Officer |
- 11100
|
10.79 USD |
|
2 months ago
Aug 27, 2024
|
Sell 78.1 K USD
|
Linynsky Laura A
Director |
- 7000
|
11.16 USD |
|
3 months ago
Aug 09, 2024
|
Sell 328 K USD
|
Richards C Marc
EVP, Chief Financial Officer |
- 32562
|
10.08 USD |
|
3 months ago
Aug 12, 2024
|
Sell 176 K USD
|
Richards C Marc
EVP, Chief Financial Officer |
- 17438
|
10.08 USD |
|
11 months ago
Dec 14, 2023
|
Sell 9.33 K USD
|
Moore Mary Ann E
EVP, General Counsel & Sec |
- 970
|
9.62 USD |
|
11 months ago
Dec 14, 2023
|
Sell 11.1 K USD
|
Moore Mary Ann E
EVP, General Counsel & Sec |
- 1150
|
9.62 USD |
|
11 months ago
Dec 14, 2023
|
Sell 55.2 K USD
|
Swift James D
Chief Executive Officer |
- 5764
|
9.58 USD |
|
1 year ago
Jun 14, 2023
|
Sell 187 K USD
|
Swift James D
Chief Executive Officer |
- 13193
|
14.14 USD |
|
1 year ago
May 25, 2023
|
Sell 438 K USD
|
ORDAN MARK S
Director |
- 33000
|
13.26 USD |
|
1 year ago
May 18, 2023
|
Sell 244 K USD
|
Weis Shirley A
Director |
- 17993
|
13.55 USD |
|
1 year ago
May 19, 2023
|
Sell 13.7 K USD
|
Weis Shirley A
Director |
- 1007
|
13.63 USD |
|
1 year ago
Nov 21, 2022
|
Sell 342 K USD
|
ORDAN MARK S
Chief Executive Officer |
- 22166
|
15.45 USD |
|
2 years ago
Nov 07, 2022
|
Sell 367 K USD
|
Swift James D
EVP, Chief Operating Officer |
- 24000
|
15.31 USD |
|
2 years ago
Jan 10, 2022
|
Sell 1.58 M USD
|
MEDEL ROGER MD
Director |
- 59893
|
26.44 USD |
|
2 years ago
Jan 11, 2022
|
Sell 1.07 M USD
|
MEDEL ROGER MD
Director |
- 40107
|
26.58 USD |
|
2 years ago
Jan 05, 2022
|
Sell 347 K USD
|
MEDEL ROGER MD
Director |
- 12639
|
27.42 USD |
|
2 years ago
Dec 31, 2021
|
Sell 178 K USD
|
MEDEL ROGER MD
Director |
- 6564
|
27.16 USD |
|
2 years ago
Jan 04, 2022
|
Sell 2.4 M USD
|
MEDEL ROGER MD
Director |
- 87361
|
27.43 USD |
|
2 years ago
Dec 30, 2021
|
Sell 1.23 M USD
|
MEDEL ROGER MD
Director |
- 45397
|
27.19 USD |
|
2 years ago
Dec 27, 2021
|
Sell 1.82 M USD
|
MEDEL ROGER MD
Director |
- 66868
|
27.17 USD |
|
2 years ago
Dec 28, 2021
|
Sell 1.21 M USD
|
MEDEL ROGER MD
Director |
- 44514
|
27.28 USD |
|
2 years ago
Dec 29, 2021
|
Sell 682 K USD
|
MEDEL ROGER MD
Director |
- 25000
|
27.28 USD |
|
3 years ago
Nov 10, 2021
|
Sell 250 K USD
|
Hinson Roger Mack
Pres., PDX & OBX Medical Group |
- 8800
|
28.38 USD |
|
3 years ago
Nov 10, 2021
|
Sell 142 K USD
|
Pepia John C
Principal Accounting Officer |
- 5000
|
28.45 USD |
|
3 years ago
Oct 29, 2021
|
Sell 248 K USD
|
Pepia John C
Principal Accounting Officer |
- 9238
|
26.87 USD |
|
3 years ago
Oct 28, 2021
|
Sell 301 K USD
|
MEDEL ROGER MD
Director |
- 10387
|
29 USD |
|
3 years ago
Oct 04, 2021
|
Sell 36.8 K USD
|
MEDEL ROGER MD
Director |
- 1270
|
29 USD |
|
3 years ago
Sep 02, 2021
|
Sell 318 K USD
|
Pepia John C
Principal Accounting Officer |
- 10000
|
31.83 USD |
|
3 years ago
Aug 30, 2021
|
Sell 3.33 M USD
|
ORDAN MARK S
Chief Executive Officer |
- 95000
|
35.09 USD |
|
3 years ago
Aug 10, 2021
|
Sell 285 K USD
|
Hinson Roger Mack
Pres., PDX & OBX Medical Group |
- 8799
|
32.35 USD |
|
3 years ago
Jul 01, 2021
|
Sell 3.03 M USD
|
MEDEL ROGER MD
Director |
- 100000
|
30.31 USD |
|
3 years ago
Apr 01, 2021
|
Sell 2.52 M USD
|
MEDEL ROGER MD
Director |
- 99218
|
25.4 USD |
|
3 years ago
Apr 01, 2021
|
Sell 20.2 K USD
|
MEDEL ROGER MD
Director |
- 782
|
25.81 USD |
|
3 years ago
Jan 04, 2021
|
Sell 1.1 M USD
|
MEDEL ROGER MD
Director |
- 47039
|
23.41 USD |
|
3 years ago
Jan 04, 2021
|
Sell 1.27 M USD
|
MEDEL ROGER MD
Director |
- 52961
|
23.89 USD |
|
3 years ago
Dec 09, 2020
|
Sell 1.54 M USD
|
MEDEL ROGER MD
Director |
- 66806
|
23.002 USD |
|
3 years ago
Dec 10, 2020
|
Sell 765 K USD
|
MEDEL ROGER MD
Director |
- 33194
|
23.0439 USD |
|
4 years ago
Sep 15, 2020
|
Sell 190 K USD
|
Nikolopoulos Nicholas J
EVP Chf Strategy & Growth Offi |
- 10000
|
19.0179 USD |
|
4 years ago
Sep 15, 2020
|
Sell 416 K USD
|
Andreano Dominic J
EVP, General Counsel and Secy |
- 22000
|
18.9284 USD |
|
5 years ago
Nov 01, 2019
|
Sell 114 K USD
|
Goldschmidt, MD Pascal J
Director |
- 5000
|
22.8806 USD |
|
5 years ago
Sep 03, 2019
|
Sell 104 K USD
|
Goldschmidt, MD Pascal J
Director |
- 5000
|
20.81 USD |
|
5 years ago
Aug 12, 2019
|
Bought 1.31 M USD
|
FERNANDEZ MICHAEL
Director |
+ 61205
|
21.3518 USD |
|
5 years ago
Aug 12, 2019
|
Bought 1.31 M USD
|
FERNANDEZ MICHAEL
Director |
+ 61204
|
21.3518 USD |
|
5 years ago
Aug 09, 2019
|
Bought 2.68 M USD
|
FERNANDEZ MICHAEL
Director |
+ 124553
|
21.524 USD |
|
5 years ago
Aug 09, 2019
|
Bought 2.68 M USD
|
FERNANDEZ MICHAEL
Director |
+ 124553
|
21.524 USD |
|
5 years ago
Aug 08, 2019
|
Bought 1.39 M USD
|
FERNANDEZ MICHAEL
Director |
+ 64242
|
21.677 USD |
|
5 years ago
Aug 08, 2019
|
Bought 1.39 M USD
|
FERNANDEZ MICHAEL
Director |
+ 64243
|
21.677 USD |
|
5 years ago
Mar 13, 2019
|
Sell 100 K USD
|
Goldschmidt, MD Pascal J
Director |
- 3300
|
30.4033 USD |
|
5 years ago
Mar 07, 2019
|
Sell 139 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 4608
|
30.1615 USD |
|
5 years ago
Mar 01, 2019
|
Sell 212 K USD
|
Clark David A.
Chief Operating Officer |
- 6452
|
32.8987 USD |
|
5 years ago
Mar 01, 2019
|
Sell 399 K USD
|
CALABRO JOSEPH M
President |
- 12130
|
32.9099 USD |
|
5 years ago
Feb 20, 2019
|
Sell 46.7 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 1289
|
36.222 USD |
|
5 years ago
Jan 22, 2019
|
Sell 91.5 K USD
|
Pepia John C
Principal Accounting Officer |
- 2500
|
36.6 USD |
|
6 years ago
Aug 14, 2018
|
Sell 45 K USD
|
Pepia John C
Principal Accounting Officer |
- 935
|
48.17 USD |
|
6 years ago
Aug 14, 2018
|
Sell 74.2 K USD
|
Pepia John C
Principal Accounting Officer |
- 1540
|
48.18 USD |
|
6 years ago
Aug 14, 2018
|
Sell 49.4 K USD
|
Pepia John C
Principal Accounting Officer |
- 1025
|
48.2 USD |
|
6 years ago
Jun 12, 2018
|
Sell 303 K USD
|
Pepia John C
Principal Accounting Officer |
- 6516
|
46.5583 USD |
|
6 years ago
Jun 12, 2018
|
Sell 648 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 13942
|
46.4621 USD |
|
6 years ago
Jun 11, 2018
|
Sell 845 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 18000
|
46.9477 USD |
|
6 years ago
Jun 01, 2018
|
Sell 1 M USD
|
CALABRO JOSEPH M
President and COO |
- 22186
|
45.1969 USD |
|
6 years ago
Jun 01, 2018
|
Sell 524 K USD
|
Clark David A.
Pres. Mednax Natl Med Group |
- 11607
|
45.1534 USD |
|
6 years ago
May 22, 2018
|
Sell 139 K USD
|
Pepia John C
Principal Accounting Officer |
- 3000
|
46.43 USD |
|
6 years ago
Mar 13, 2018
|
Sell 175 K USD
|
Pepia John C
Principal Accounting Officer |
- 3000
|
58.3542 USD |
|
6 years ago
Dec 12, 2017
|
Sell 155 K USD
|
Pepia John C
Principal Accounting Officer |
- 3000
|
51.58 USD |
|
7 years ago
Nov 03, 2017
|
Sell 454 K USD
|
ALVAREZ CESAR L
Director |
- 10668
|
42.5923 USD |
|
7 years ago
Sep 12, 2017
|
Sell 129 K USD
|
Pepia John C
Principal Accounting Officer |
- 3000
|
42.85 USD |
|
7 years ago
Jun 14, 2017
|
Sell 113 K USD
|
Goldschmidt, MD Pascal J
Director |
- 1969
|
57.57 USD |
|
7 years ago
Jun 01, 2017
|
Sell 561 K USD
|
Clark David A.
Pres. Mednax Natl Med Group |
- 10202
|
54.9932 USD |
|
7 years ago
Jun 01, 2017
|
Sell 1.28 M USD
|
CALABRO JOSEPH M
President and COO |
- 23327
|
54.9978 USD |
|
7 years ago
May 05, 2017
|
Sell 434 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 7778
|
55.8219 USD |
|
7 years ago
May 05, 2017
|
Bought 1.21 M USD
|
Kadre Manuel
Director |
+ 21704
|
55.7887 USD |
|
7 years ago
Mar 15, 2017
|
Sell 462 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 6517
|
70.8371 USD |
|
7 years ago
Feb 23, 2017
|
Sell 743 K USD
|
SOSA ENRIQUE
Director |
- 10668
|
69.6532 USD |
|
7 years ago
Feb 17, 2017
|
Sell 1.06 M USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 15164
|
70.0083 USD |
|
7 years ago
Feb 16, 2017
|
Sell 69.6 K USD
|
Pepia John C
Principal Accounting Officer |
- 1000
|
69.5812 USD |
|
7 years ago
Feb 16, 2017
|
Sell 104 K USD
|
Pepia John C
Principal Accounting Officer |
- 1500
|
69.581 USD |
|
7 years ago
Feb 16, 2017
|
Sell 1.49 M USD
|
GABOS PAUL G
Director |
- 21336
|
69.6318 USD |
|
7 years ago
Feb 16, 2017
|
Sell 418 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 6000
|
69.5885 USD |
|
7 years ago
Feb 10, 2017
|
Sell 1.72 M USD
|
Goldschmidt, MD Pascal J
Director |
- 25294
|
67.8152 USD |
|
7 years ago
Feb 09, 2017
|
Sell 362 K USD
|
WALDEMAR, MD CARLO A
Director |
- 5334
|
67.9014 USD |
|
7 years ago
Feb 09, 2017
|
Sell 362 K USD
|
WALDEMAR, MD CARLO A
Director |
- 5334
|
67.9014 USD |
|
7 years ago
Jan 17, 2017
|
Sell 710 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 10000
|
70.95 USD |
|
7 years ago
Dec 07, 2016
|
Bought 140 K USD
|
Goldschmidt, MD Pascal J
Director |
+ 2100
|
66.515 USD |
|
8 years ago
Sep 14, 2016
|
Sell 30.9 K USD
|
Goldschmidt, MD Pascal J
Director |
- 475
|
65 USD |
|
8 years ago
Sep 14, 2016
|
Sell 36.8 K USD
|
Goldschmidt, MD Pascal J
Director |
- 566
|
65.01 USD |
|
8 years ago
Sep 14, 2016
|
Sell 19.7 K USD
|
Goldschmidt, MD Pascal J
Director |
- 303
|
65.02 USD |
|
8 years ago
Sep 14, 2016
|
Sell 10.1 K USD
|
Goldschmidt, MD Pascal J
Director |
- 156
|
65.03 USD |
|
8 years ago
Jun 13, 2016
|
Sell 270 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 3922
|
68.8 USD |
|
8 years ago
Jun 08, 2016
|
Sell 376 K USD
|
WALDEMAR, MD CARLO A
Director |
- 5334
|
70.5 USD |
|
8 years ago
Jun 07, 2016
|
Sell 1.88 M USD
|
WAGNER KARL B
President, Eastern Division |
- 27482
|
68.45 USD |
|
8 years ago
Jun 07, 2016
|
Sell 1.88 M USD
|
WAGNER KARL B
President, Eastern Division |
- 27482
|
68.45 USD |
|
8 years ago
Jun 01, 2016
|
Sell 777 K USD
|
Clark David A.
President, Western Division |
- 11470
|
67.7825 USD |
|
8 years ago
Jun 01, 2016
|
Sell 1 M USD
|
Stanley Michael D
President, Clinical Services |
- 14778
|
67.7838 USD |
|
8 years ago
Jun 01, 2016
|
Sell 1.92 M USD
|
CALABRO JOSEPH M
President and COO |
- 28347
|
67.781 USD |
|
8 years ago
May 16, 2016
|
Sell 206 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 3000
|
68.53 USD |
|
8 years ago
May 02, 2016
|
Sell 666 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 9350
|
71.2177 USD |
|
8 years ago
Mar 11, 2016
|
Sell 202 K USD
|
Goldschmidt, MD Pascal J
Director |
- 3100
|
65 USD |
|
8 years ago
Feb 29, 2016
|
Sell 716 K USD
|
GABOS PAUL G
Director |
- 10668
|
67.1546 USD |
|
8 years ago
Dec 11, 2015
|
Sell 373 K USD
|
Goldschmidt, MD Pascal J
Director |
- 5250
|
70.9864 USD |
|
9 years ago
Sep 08, 2015
|
Sell 864 K USD
|
ALVAREZ CESAR L
Director |
- 10668
|
81.0029 USD |
|
9 years ago
Aug 27, 2015
|
Sell 8.03 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 100000
|
80.2741 USD |
|
9 years ago
Jul 31, 2015
|
Sell 834 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 10000
|
83.4482 USD |
|
9 years ago
Jul 31, 2015
|
Sell 124 K USD
|
Goldschmidt, MD Pascal J
Director |
- 1500
|
82.3559 USD |
|
9 years ago
Jun 08, 2015
|
Sell 2.66 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 37820
|
70.2762 USD |
|
9 years ago
Jun 01, 2015
|
Sell 1.31 M USD
|
Stanley Michael D
Pres., Pediatrix Medical Group |
- 18522
|
70.4795 USD |
|
9 years ago
Jun 01, 2015
|
Sell 1.03 M USD
|
Clark David A.
COO, Pediatrix Medical Group |
- 14654
|
70.4779 USD |
|
9 years ago
Jun 01, 2015
|
Sell 1.03 M USD
|
Clark David A.
COO, Pediatrix Medical Group |
- 14654
|
70.4779 USD |
|
9 years ago
Jun 01, 2015
|
Sell 2.67 M USD
|
CALABRO JOSEPH M
President and COO |
- 37918
|
70.4794 USD |
|
9 years ago
Jun 03, 2015
|
Sell 4.95 M USD
|
CALABRO JOSEPH M
President and COO |
- 70153
|
70.5199 USD |
|
9 years ago
Mar 09, 2015
|
Sell 606 K USD
|
Goldschmidt, MD Pascal J
Director |
- 8500
|
71.2539 USD |
|
9 years ago
Feb 26, 2015
|
Sell 7.16 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 100000
|
71.6124 USD |
|
9 years ago
Feb 20, 2015
|
Sell 763 K USD
|
WALDEMAR, MD CARLO A
Director |
- 10668
|
71.5 USD |
|
9 years ago
Feb 06, 2015
|
Sell 226 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 3200
|
70.75 USD |
|
9 years ago
Feb 06, 2015
|
Sell 577 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 8250
|
69.95 USD |
|
9 years ago
Feb 02, 2015
|
Sell 1.2 M USD
|
GABOS PAUL G
Director |
- 17584
|
68.0664 USD |
|
9 years ago
Feb 02, 2015
|
Sell 1.2 M USD
|
GABOS PAUL G
Director |
- 17584
|
68.0664 USD |
|
9 years ago
Jan 30, 2015
|
Sell 246 K USD
|
Hawk William C
COO American Anesthesiology |
- 3598
|
68.4981 USD |
|
10 years ago
Nov 14, 2014
|
Sell 3.21 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 51290
|
62.5887 USD |
|
10 years ago
Nov 11, 2014
|
Sell 2.63 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 42012
|
62.5422 USD |
|
10 years ago
Nov 13, 2014
|
Sell 1.34 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 21428
|
62.5605 USD |
|
10 years ago
Nov 06, 2014
|
Sell 7.84 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 125248
|
62.5987 USD |
|
10 years ago
Nov 07, 2014
|
Sell 224 K USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 3585
|
62.5124 USD |
|
10 years ago
Nov 03, 2014
|
Sell 680 K USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 10881
|
62.5206 USD |
|
10 years ago
Nov 04, 2014
|
Sell 941 K USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 15052
|
62.516 USD |
|
10 years ago
Nov 05, 2014
|
Sell 9.01 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 143912
|
62.6149 USD |
|
10 years ago
Oct 30, 2014
|
Sell 528 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 8800
|
60 USD |
|
10 years ago
Oct 30, 2014
|
Sell 2.5 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 40000
|
62.5 USD |
|
10 years ago
Oct 30, 2014
|
Sell 2.29 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 36509
|
62.6302 USD |
|
10 years ago
Oct 31, 2014
|
Sell 1.57 M USD
|
MEDEL ROGER MD
Chief Executive Officer |
- 25083
|
62.5173 USD |
|
10 years ago
Jul 30, 2014
|
Sell 4.8 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 80000
|
60 USD |
|
10 years ago
Jun 10, 2014
|
Sell 132 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 2252
|
58.48 USD |
|
10 years ago
Jun 05, 2014
|
Sell 398 K USD
|
Hawk William C
COO American Anesthesiology |
- 6911.0706
|
57.66 USD |
|
10 years ago
Jun 06, 2014
|
Sell 2.61 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 44596
|
58.5334 USD |
|
10 years ago
Jun 02, 2014
|
Sell 2.18 M USD
|
CALABRO JOSEPH M
President and COO |
- 38228
|
56.9768 USD |
|
10 years ago
Jun 02, 2014
|
Sell 1.03 M USD
|
Stanley Michael D
Pres., Pediatrix Medical Group |
- 18006
|
56.997 USD |
|
10 years ago
Jun 02, 2014
|
Sell 925 K USD
|
Clark David A.
COO, Pediatrix Medical Group |
- 16230
|
56.999 USD |
|
10 years ago
May 09, 2014
|
Sell 2.47 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 43274
|
57.0952 USD |
|
10 years ago
May 09, 2014
|
Sell 2.07 M USD
|
WAGNER KARL B
Pres, American Anesthesiology |
- 36250
|
57.0947 USD |
|
10 years ago
May 09, 2014
|
Sell 1.71 M USD
|
Goldschmidt, MD Pascal J
Director |
- 30000
|
57.11 USD |
|
10 years ago
May 07, 2014
|
Sell 7.01 M USD
|
CALABRO JOSEPH M
President and COO |
- 122990
|
56.9845 USD |
|
10 years ago
May 08, 2014
|
Sell 837 K USD
|
CALABRO JOSEPH M
President and COO |
- 14510
|
57.6896 USD |
|
10 years ago
Feb 20, 2014
|
Sell 183 K USD
|
Andreano Dominic J
SVP, General Counsel and Secy |
- 3000
|
61 USD |
|
10 years ago
Feb 10, 2014
|
Sell 591 K USD
|
WALDEMAR, MD CARLO A
Director |
- 10668
|
55.4 USD |
|
10 years ago
Feb 10, 2014
|
Sell 4.9 M USD
|
CALABRO JOSEPH M
President and COO |
- 87719
|
55.8151 USD |
|
10 years ago
Feb 06, 2014
|
Sell 385 K USD
|
CALABRO JOSEPH M
President and COO |
- 6999
|
55.033 USD |
|
10 years ago
Feb 07, 2014
|
Sell 3.05 M USD
|
CALABRO JOSEPH M
President and COO |
- 55282
|
55.1992 USD |
|
10 years ago
Feb 07, 2014
|
Sell 3.05 M USD
|
CALABRO JOSEPH M
President and COO |
- 55282
|
55.1992 USD |
|
10 years ago
Feb 10, 2014
|
Sell 4.9 M USD
|
CALABRO JOSEPH M
President and COO |
- 87719
|
55.8151 USD |
|
10 years ago
Feb 06, 2014
|
Sell 385 K USD
|
CALABRO JOSEPH M
President and COO |
- 6999
|
55.033 USD |
|
10 years ago
Feb 03, 2014
|
Sell 508 K USD
|
Lopez-Blanco Vivian
Chief Financial Officer |
- 9200
|
55.2 USD |
7. News
Pediatrix Medical Group (MD) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Pediatrix Medical Group (MD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
zacks.com
- 1 week ago
Pediatrix Medical Stock Soars 30.5% Since Q3 Earnings Beat
MD expects transformational and restructuring-related expenses to be $48 million in 2024.
zacks.com
- 1 week ago
MD vs. AVTR: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two companies is the best option for those looking for undervalued stocks?
zacks.com
- 1 week ago
Pediatrix Medical Group, Inc. (MD) Q3 2024 Earnings Call Transcript
Pediatrix Medical Group, Inc. (NYSE:MD ) Q3 2024 Earnings Conference Call November 1, 2024 9:00 AM ET Company Participants Charles Lynch - Senior Vice President, Finance and Strategy James Swift - Chief Executive Officer Kasandra Rossi - Executive Vice President, Chief Financial Officer and Treasure Conference Call Participants Jack Senft - William Blair Jack Slevin - Jefferies A.J. Rice - UBS Operator Ladies and gentlemen, thank you for standing by and welcome to the 2024 Third Quarter's Earnings Conference.
seekingalpha.com
- 2 weeks ago
Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.32 per share a year ago.
zacks.com
- 2 weeks ago
Pediatrix Medical Group Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
businesswire.com
- 2 weeks ago
Pediatrix Medical Group (MD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Pediatrix Medical Group (MD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zacks.com
- 3 weeks ago
Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2024 Third Quarter Conference Call/Webcast Scheduled for Friday, November 1, 2024.
businesswire.com
- 1 month ago
MD vs. AVTR: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Services sector might want to consider either Pediatrix Medical Group (MD) or Avantor, Inc. (AVTR). But which of these two stocks offers value investors a better bang for their buck right now?
zacks.com
- 1 month ago
Pediatrix Medical Up 45.8% in 3 Months: Is it Too Late to Jump In?
MD remains one of the best-positioned pediatric service providers with favorable valuation to achieve margin improvement.
zacks.com
- 2 months ago
Pediatrix Medical Group (MD)'s Technical Outlook is Bright After Key Golden Cross
After reaching an important support level, Pediatrix Medical Group, Inc. (MD) could be a good stock pick from a technical perspective. MD recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
zacks.com
- 2 months ago
Why Is Pediatrix Medical Group (MD) Up 9.5% Since Last Earnings Report?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
zacks.com
- 2 months ago
8. Profile Summary
Pediatrix Medical Group, Inc. MD
COUNTRY
US
INDUSTRY
Medical - Care Facilities
MARKET CAP
$ 1.22 B
Dividend Yield
0.00%
Description
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Contact
1301 Concord Terrace, Sunrise, FL, 33323
https://www.mednax.com
IPO Date
Sept. 20, 1995
Employees
5450
Officers
Ms. Kasandra H. Rossi
Executive Vice President, Treasurer & Chief Financial Officer
Dr. Michael Dwyer M.D.
President of Regional Operations (South-Central)
Mr. John C. Pepia
Senior Vice President & Chief Accounting Officer
Mr. Mike Ashford
President of Regional Operations (Central)
Ms. Cheryl M. VanPatten
Senior Vice President & Chief Information Officer
Dr. James D. Swift M.D.
Chief Executive Officer & Director
Mr. Charles W. Lynch C.F.A.
Senior Vice President of Finance, Strategy & Investor Relations
Ms. Meghan K. Lublin
Senior Vice President, Chief Brand & Communications Officer
Ms. Debra McRoberts
Senior Vice President of People Services
Mr. Daniel Patrick Corcoran
Senior Vice President of Administration & Managed Care